Short-term clinical outcomes of ticagrelor versus clopidogrel after percutaneous coronary intervention in patients with myocardial infarction: A randomized clinical trial study

Background: Reperfusion can be done through primary percutaneous coronary intervention (PPCI) and thrombolytic administration. Patients with myocardial infarction should receive antiplatelet drugs from the P2Y12 receptor inhibitor category (such as ticagrelor, prasugrel, and clopidogrel). Based on r...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Salman Nikfarjam, Yasaman Borghei, Arsalan Salari, Seyyed Mehrad Miraftabi, Bahare Gholami-Chaboki, Seyyed Aboozar Fakhr-Moosavi
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wolters Kluwer Medknow Publications 2023-01-01
Serie:	Research in Cardiovascular Medicine
Soggetti:	clopidogrel myocardial infarction percutaneous coronary intervention ticagrelor
Accesso online:	http://www.rcvmonline.com/article.asp?issn=2251-9572;year=2023;volume=12;issue=2;spage=56;epage=60;aulast=Nikfarjam
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!